Stage III Pancreatic Cancer Trial Recruitment

This project is aimed at increasing awareness and participation in the DIRECT clinical study, a trial of the NanoKnife® Irreversible Electroporation System for treatment of stage III pancreatic cancer. The NanoKnife® System has received 510(k) clearance from the Food and Drug Administration for the surgical ablation of soft tissue. It uses low energy direct current electrical pulses to permanently open pores in target cell membranes. Call 651-410-3582 or click here to learn more.